Intuitive Surgical, Inc.
ISRG Healthcare Medical Instruments & Supplies
Intuitive Surgical, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $10.1 billion, up 20.5% from fiscal 2024. In the quarter to June 2026, revenue grew 18.5%, EPS grew 25.5% and free cash flow grew 69.3%, each against the same quarter a year earlier. Member of the S&P 500 and Nasdaq 100; revenue growth for five consecutive years, operating cash flow growth for three.
Follow ISRG
Intuitive Surgical, Inc. (ISRG) Total debt
Intuitive Surgical, Inc.'s total debt at the end of fiscal 2022 was $94.0M, up 8.05% from $87.0M in fiscal 2021. Intuitive Surgical, Inc. ranks 23rd of 54 Medical Instruments & Supplies companies by total debt.
Total debt, annual
Embed this chart
Annual newest first
| Period | Total debt | Change |
|---|---|---|
| FY2022 | $94.0M | 8.05% |
| FY2021 | $87.0M | 8.75% |
| FY2020 | $80.0M | 3.90% |
| FY2019 | $77.0M | — |
Quarterly newest first
| Period | Total debt | Change |
|---|---|---|
| Dec 2022 | $94.0M | 8.05% |
| Dec 2021 | $87.0M | 8.75% |
| Dec 2020 | $80.0M | 3.90% |
| Dec 2019 | $77.0M | — |
Total debt against peers
| Company | Total debt |
|---|---|
| BDX Becton, Dickinson and Company compare | $13.5B |
| MDLN Medline Inc. compare | $12.6B |
| BAX Baxter International Inc. compare | $9.5B |
| SOLV Solventum Corporation compare | $5.3B |
| ALC Alcon compare | $4.7B |
| RGEN Repligen Corporation compare | $551.0M |
| RMD ResMed Inc. compare | $399.4M |
| WST West Pharmaceutical Services, Inc. compare | $202.9M |
| ISRG Intuitive Surgical, Inc. | $94.0M |
What Total debt is
Total Debt tells an investor how much a company has borrowed in all, whether the money is due within a year or later.
Long Term Debt (Total) + Current Part of Debt
More on ISRG
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement